Pfizer Inc (PFE) - Upjohn Revenue (DISCONTINUED) (I:PIPFEUR)
Level Chart
Basic Info
|
Pfizer Inc (PFE) - Upjohn Revenue is at a current level of 0.000, unchanged from 0.00 one year ago. This is a change of N/A from one year ago. |
|
Upjohn Revenue refers to the revenue generated from its Upjohn business, a business unit of Pfizer and a global pharmaceutical company with a portfolio of well-established primarily off-patent branded and generic medicines, headquartered in China. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 0.00 |
| Latest Period | 2022 |
| Last Updated | Oct 5 2023, 11:15 EDT |
| Average Growth Rate | -53.58% |
| Value from 1 Year Ago | 0.00 |
| Change from 1 Year Ago | N/A |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.00 |
| December 31, 2018 | 12.48B |
| December 31, 2017 | 13.45B |
Basic Info
|
Pfizer Inc (PFE) - Upjohn Revenue is at a current level of 0.000, unchanged from 0.00 one year ago. This is a change of N/A from one year ago. |
|
Upjohn Revenue refers to the revenue generated from its Upjohn business, a business unit of Pfizer and a global pharmaceutical company with a portfolio of well-established primarily off-patent branded and generic medicines, headquartered in China. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 0.00 |
| Latest Period | 2022 |
| Last Updated | Oct 5 2023, 11:15 EDT |
| Average Growth Rate | -53.58% |
| Value from 1 Year Ago | 0.00 |
| Change from 1 Year Ago | N/A |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |